- Country: USA
- Summary: I-Corps Program at the National Cancer Institute
- UST Ref No: 124596047
- Deadline: 01 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N91025Q00052
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
It is anticipated that this sole source acquisition will be conducted under the authority of 41 United States Code (U.S.C.) 253(c)(1) as set forth in Federal Acquisition Regulation (FAR) 6.302- 1(b)(1)(i). It is anticipated that this acquisition will be processed in accordance with procedures as stated in FAR Part 15 Contracting by Negotiation via request for written proposal. The North American Industry Classification System code is 541611 and the business size standard is $24.5M.
There is no solicitation at this time. When the solicitation is issued, it is anticipated that only one (1) award will be made and awarded as a firm fixed price type Contract. The Period of Performance is estimated to one (1) 12-month base period, plus two (2) 12-month option periods.
BACKGROUND
The National Cancer Institute (NCI)-s Small Business Innovation Research (SBIR) Development Center-s core objectives are to help investigators translate scientific discoveries into impactful healthcare solutions, manage early-stage product development across NCI, inspire and support a diverse entrepreneurial workforce, and highlight NCI's role in improving patient care and driving economic growth.
NCI SBIR requires the Innovation Corps (I-Corps) program which offers crucial support to researchers and innovators through its hands-on training program, focusing on customer discovery and business model development. This structured approach effectively evaluates the commercial potential of scientific research, laying the foundation for new ventures and contributing to robust economic growth. Since 2014, the National Institutes of Health (NIH) has implemented and assessed the I-Corps program and foster the growth of the national biomedical innovation ecosystem.
The NCI SBIR Development Center aids the entrepreneurial community that aligns with the mission of the NCI in validating the health impacts of promising scientific discoveries and advancing them into healthcare... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINI-Corps Program at the National Cancer Institute - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for I-Corps Program at the National Cancer Institute. This tender is published on USARFP under UST Ref No: 124596047 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
